Global Vaccine Market, 2021-2027

November 2021 | 79 pages | ID: G42AD261FFD6EN
Gen Consulting Company

Abstracts

Vaccination is a simple, safe, and effective way of protecting people against harmful diseases before they come into contact with them. The global vaccine market is anticipated to reach valuation of ~USD 51,149 million by 2027, representing a CAGR of 6.7% from 2021 to 2027 as per the latest report by Gen Consulting Company.

The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into global vaccine market. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, growth rate and market segments.

The vaccine market is segmented on the basis of vaccine type, indication, end user, and region. The vaccine market is segmented as below:

By vaccine type:

• recombinant & conjugate vaccines
• live attenuated vaccines
• inactivated vaccines
• toxoid vaccines
• others

By indication:

• diphtheria, pertussis, & tetanus (DTP)
• human papillomavirus (HPV)
• influenza
• measles, mumps, & rubella (MMR)
• meningococcal disease
• pneumococcal disease
• rotavirus
• others

By end user:

• pediatric
• adults

By region:

• region
• Asia Pacific
• Europe
• North America
• Rest of the World (RoW)

The report has also analysed the competitive landscape of the global vaccine market with some of the key players being Abbott Laboratories, AstraZeneca plc, Bavarian Nordic A/S, Emergent BioSolutions Inc., GlaxoSmithKline plc, Johnson & Johnson (J&J), Merck & Co., Inc., Merck & Co., Inc., Pfizer Inc., Sanofi S.A., among others.

*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES

Historical & Forecast Period

This research report provides analysis for each segment from 2017 to 2027 considering 2020 to be the base year.

Scope of the Report

• To analyze and forecast the market size of the global vaccine market.
• To classify and forecast the global vaccine market based on vaccine type, indication, end user, and region.
• To identify drivers and challenges for the global vaccine market.
• To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global vaccine market.
• To identify and analyze the profile of leading players operating in the global vaccine market.

Why Choose This Report

• Gain a reliable outlook of the global vaccine market forecasts from 2021 to 2027 across scenarios.
• Identify growth segments for investment.
• Stay ahead of competitors through company profiles and market data.
• The market estimate for ease of analysis across scenarios in Excel format.
• Strategy consulting and research support for three months.
• Print authentication provided for the single-user license.

Contents

PART 1. INTRODUCTION

1.1 Market definition
1.2 Key benefits
1.3 Market segment

PART 2. METHODOLOGY

2.1 Primary
2.2 Secondary

PART 3. EXECUTIVE SUMMARY

PART 4. MARKET OVERVIEW

4.1 Introduction
4.2 Market dynamics
  4.2.1 Drivers
  4.2.2 Restraints

PART 5. GLOBAL MARKET FOR VACCINE BY VACCINE TYPE

5.1 Recombinant & conjugate vaccines
  5.1.1 Market size and forecast
5.2 Live attenuated vaccines
  5.2.1 Market size and forecast
5.3 Inactivated vaccines
  5.3.1 Market size and forecast
5.4 Toxoid vaccines
  5.4.1 Market size and forecast
5.5 Others
  5.5.1 Market size and forecast

PART 6. GLOBAL MARKET FOR VACCINE BY INDICATION

6.1 Diphtheria, pertussis, & tetanus (DTP)
  6.1.1 Market size and forecast
6.2 Human papillomavirus (HPV)
  6.2.1 Market size and forecast
6.3 Influenza
  6.3.1 Market size and forecast
6.4 Measles, mumps, & rubella (MMR)
  6.4.1 Market size and forecast
6.5 Meningococcal disease
  6.5.1 Market size and forecast
6.6 Pneumococcal disease
  6.6.1 Market size and forecast
6.7 Rotavirus
  6.7.1 Market size and forecast
6.8 Others
  6.8.1 Market size and forecast

PART 7. GLOBAL MARKET FOR VACCINE BY END USER

7.1 Pediatric
  7.1.1 Market size and forecast
7.2 Adults
  7.2.1 Market size and forecast

PART 8. GLOBAL MARKET FOR VACCINE BY REGION

8.1 Asia Pacific
  8.1.1 Market size and forecast
8.2 Europe
  8.2.1 Market size and forecast
8.3 North America
  8.3.1 Market size and forecast
8.4 Rest of the World (RoW)
  8.4.1 Market size and forecast

PART 9. KEY COMPETITOR PROFILES

9.1 Abbott Laboratories
9.2 AstraZeneca plc
9.3 Bavarian Nordic A/S
9.4 Emergent BioSolutions Inc.
9.5 GlaxoSmithKline plc
9.6 Johnson & Johnson (J&J)
9.7 Merck & Co., Inc.
9.8 Merck & Co., Inc.
9.9 Pfizer Inc.
9.10 Sanofi S.A.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
DISCLAIMER
ABOUT GEN CONSULTING COMPANY